{"id":165711,"name":"ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.)","slug":"association-for-accessible-medicines-formerly-generic-pharmaceutical-assoc","state":"DC","country":"United States of America","description":"National trade organization representing the interests of generic drug manufacturers.","totalSpending":1590000,"filings":34,"yearlySpending":[{"year":2018,"income":200000},{"year":2019,"income":200000},{"year":2020,"income":190000},{"year":2021,"income":160000},{"year":2022,"income":240000},{"year":2023,"income":160000},{"year":2024,"income":200000},{"year":2025,"income":240000}],"issues":["HCR","TAX","MMM","TRD","PHA","DEF","CPT"],"firms":["CAPITOL HILL CONSULTING GROUP"],"lobbyists":["BRIAN SUTTER","DAVID JORY","DAVID EDWARDS","WILLIAM SOUTHERLAND","THOMAS WHARTON","EMILY WILKINSON-HOLLAND","CHRISTOPHER DAVIS","KIMBERLEE TRZECIAK"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["- Issues relating to bioequivalence and related administrative procedures. \n- Issues relating to prescription drug abuse. \n- Issues relating to the labeling of generic drugs. \n- FAST Generics Act / CR","Issues related to tax reform concerning Border Adjustment Tax","Provisions from the Bipartisan Budget Act of 2015 concerning the Medicaid rebate program. \nIssues related to the Medicare low-income subsidy. \nIssues related to the cost of prescription drugs.\nIssues ","- Issues relating to bioequivalence and related administrative procedures. \n- Issues relating to prescription drug abuse. \n- Issues relating to the labeling of generic drugs. \n- FAST Generics Act / CR","Issues related to tax reform concerning Border Adjustment Tax"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}